JP2005047851A5 - - Google Patents

Download PDF

Info

Publication number
JP2005047851A5
JP2005047851A5 JP2003281590A JP2003281590A JP2005047851A5 JP 2005047851 A5 JP2005047851 A5 JP 2005047851A5 JP 2003281590 A JP2003281590 A JP 2003281590A JP 2003281590 A JP2003281590 A JP 2003281590A JP 2005047851 A5 JP2005047851 A5 JP 2005047851A5
Authority
JP
Japan
Prior art keywords
coenzyme
ubidecarenone
effective
heart failure
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003281590A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005047851A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2003281590A priority Critical patent/JP2005047851A/ja
Priority claimed from JP2003281590A external-priority patent/JP2005047851A/ja
Publication of JP2005047851A publication Critical patent/JP2005047851A/ja
Publication of JP2005047851A5 publication Critical patent/JP2005047851A5/ja
Pending legal-status Critical Current

Links

JP2003281590A 2003-07-29 2003-07-29 ユビデカレノン含有組成物 Pending JP2005047851A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003281590A JP2005047851A (ja) 2003-07-29 2003-07-29 ユビデカレノン含有組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003281590A JP2005047851A (ja) 2003-07-29 2003-07-29 ユビデカレノン含有組成物

Publications (2)

Publication Number Publication Date
JP2005047851A JP2005047851A (ja) 2005-02-24
JP2005047851A5 true JP2005047851A5 (enExample) 2006-04-20

Family

ID=34267044

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003281590A Pending JP2005047851A (ja) 2003-07-29 2003-07-29 ユビデカレノン含有組成物

Country Status (1)

Country Link
JP (1) JP2005047851A (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4970734B2 (ja) * 2005-03-03 2012-07-11 株式会社コーセー 透明水性組成物
JP2007074937A (ja) * 2005-09-12 2007-03-29 Marubeni Nisshin Feed Co Ltd コエンザイムq10強化卵及びその生産方法並びに家禽用配合飼料
JP4799102B2 (ja) * 2005-09-26 2011-10-26 日清オイリオグループ株式会社 油性皮膚用組成物
US8574568B2 (en) 2005-11-07 2013-11-05 Kaneka Corporation Reduced coenzyme Q10-containing composition comprising a surfactant which is stable against oxidation and method for stabilization by mixing with surfactant(s)
JP2007181408A (ja) * 2005-12-31 2007-07-19 Nippon Same No Kai Bussan Kk スクアレン加工食品
JP4644135B2 (ja) * 2006-02-09 2011-03-02 太陽化学株式会社 コエンザイムq10含有組成物
JP2008005813A (ja) * 2006-06-30 2008-01-17 Ezaki Glico Co Ltd コエンザイムq10含有チョコレート
CN104114035B (zh) * 2012-02-15 2017-07-07 日清奥利友集团株式会社 饲料用组合物、饲料、及饲料的制造方法
ES2851923T3 (es) * 2016-05-20 2021-09-09 Nestle Sa Triglicéridos de cadena intermedia para el tratamiento de enfermedad degenerativa de la válvula mitral en animales de compañía

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5581813A (en) * 1978-12-16 1980-06-20 Nisshin Flour Milling Co Ltd Composition containing coenzyme q10 and its perparation
JP3487881B2 (ja) * 1993-09-30 2004-01-19 太陽化学株式会社 界面活性剤
DE19509354A1 (de) * 1994-12-08 1996-06-13 Klett Loch Lore M Kombinationspräparat zur Förderung des Haarwachstums und ggf. des Haut- und Nagelwachstums sowie zur Verhinderung bzw. zur Beseitigung von Haarausfall
WO1996036316A1 (en) * 1995-05-19 1996-11-21 Abbott Laboratories Self-emulsifying formulations of lipophilic drugs
GB9608719D0 (en) * 1996-04-26 1996-07-03 Scherer Ltd R P Pharmaceutical compositions
JP3533605B2 (ja) * 2001-12-06 2004-05-31 すこやか食品株式会社 血圧降下、心臓強化、動脈硬化防止、血管保護、抗疲労、運動機能向上、エネルギー代謝効率向上、抗酸化などの諸効果を有する栄養補助食品。

Similar Documents

Publication Publication Date Title
EA200701175A1 (ru) Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний
CY1116747T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
JP2010505817A5 (enExample)
EA200400881A1 (ru) Азаарилпиперазины
RU2350333C3 (ru) Применение ивермектина для лечения дерматологических расстройств
EA200601799A1 (ru) Гидразидсодержащие соединения - ингибиторы cftr и их применение
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
CY1105127T1 (el) Συνθεση για την προληψη καρδιαγγειακων νοσων
NO20050896L (no) Probiotika for neuromuskulaere funksjoner i tarmen
JP2003526622A5 (enExample)
EA200300046A1 (ru) Быстро увеличивающаяся в объеме композиция для удерживания и контролированного выделения терапевтических агентов в желудке и лекарственные формы, включающие композицию
Klein et al. Thyroid (neuro) myopathy.
JP2005047851A5 (enExample)
JP2004519462A (ja) ハロゲン化化合物、その調製法及びその使用
EP1852114A4 (en) COMPOSITION WITH DIHOMO (GAMMA) LINE ACIDIC ACID (DGLA) AS AN ACTIVE INGREDIENTS
CA2583764A1 (en) Thrombopoietin activity modulating compounds and methods
JP2001031566A (ja) ペットの問題行動抑制組成物
ATE543491T1 (de) Kombinationspräparat enthaltend ibuprofen und paracetamol
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
WO2007081486A3 (en) Oral administration of defensins to treat intestinal diseases
AR022338A1 (es) Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal.
WO2007025229A3 (en) Compositions and their uses directed to hsp27
Divyadharsini et al. Effect of Smoking on Interleukin-1 and Reactive Oxygen Species in Periodontitis
ATE432921T1 (de) Quadratsäurederivate mit antiproliferativer wirkung
RU2006109966A (ru) Препарат "янтастим-с" для терапии и профилактики инфекционных заболеваний животных